Back

Clec7a-mediated regulation of Killer-like Lectin Receptor expression controls T cell immunity

Dambuza, I. M.; Salazar, F.; Sey, E. A.; Kastora, S. L.; Rodrigues, C.; Phillips-Brookes, A.; Harvey, J.; Drummond, R. A.; Rush, J.; Yuecel, R.; Saijo, S.; Willment, J. A.; Kaplan, D. H.; LeibundGut-Landmann, S.; Brown, G. D.

2025-12-09 immunology
10.64898/2025.12.04.692469 bioRxiv
Show abstract

Clec7a is a C-type lectin receptor (CLR) originally defined for its non-redundant role in anti-fungal immunity. Subsequent work has broadened this view, implicating Clec7a in host defense against diverse pathogens and in the pathogenesis of cancer, autoimmunity, neuroinflammation, and developmental disorders. How a single innate receptor orchestrates such wide-ranging outcomes remains unresolved. We previously demonstrated that dendritic cell (DC)-expressed Clec7a is required for protective anti-fungal immunity in the gastrointestinal tract through regulation of fungus-specific CD4 T cell responses. Here, we show that Clec7a controls the expression of multiple C-type lectins in DCs, including a cluster of killer lectin-like receptors (KLRs). Notably, we reveal that these KLRs directly regulate DC function and control CD4 T cell responses. These findings define a novel Clec7a-KLR axis that integrates innate and adaptive immunity, highlighting a regulatory pathway with broad relevance for immune homeostasis, inflammation, and host defense.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.